IP Library Granted Patent US 12,180,217
Granted Patent B2
US 12,180,217 · App. 18/601,528 · Granted Dec 31, 2024

Compounds and methods for treatment of viral infections

Inventors: Mark J. Bartlett (Castro Valley, CA); Daniel H. Byun (Foster City, CA); Yifan Deng (Milpitas, CA); Jennifer L. Cosman Ellis (Foster City, CA); Rao V. Kalla (Cupertino, CA); Richard L Mackman (Millbrae, CA); Dustin S. Siegel (Half Moon Bay, CA); Xianhuang Zeng (Redwood City, CA)
Assignee: Gilead Sciences, Inc.
C07D487/04A61K9/0053A61K45/06A61P31/14C07D519/00C07F9/6561
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,180,217
App. No.
18/601,528
Granted
Dec 31, 2024
Kind
B2
Abstract

Compounds and methods of using said compounds, singly or in combination with additional agents, and salts or pharmaceutical compositions of said compounds for the treatment of viral infections are disclosed.

Claims (15)

1. A compound of Formula:

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein the compound is

3. A compound of Formula:

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 3 , wherein the compound is

5. A compound of Formula:

or a pharmaceutically acceptable salt thereof.

6. The compound of claim 5 , wherein the compound is

7. A pharmaceutical composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

8. A pharmaceutical composition comprising the compound of claim 2 , and one or more pharmaceutically acceptable excipients.

9. A pharmaceutical composition comprising the compound of claim 3 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

10. A pharmaceutical composition comprising the compound of claim 4 , and one or more pharmaceutically acceptable excipients.

11. A pharmaceutical composition comprising the compound of claim 5 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

12. A pharmaceutical composition comprising the compound of claim 6 , and one or more pharmaceutically acceptable excipients.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2024
From: BARTLETT, MARK J.; BYUN, DANIEL H.; DENG, YIFAN; COSMAN ELLIS, JENNIFER L.; KALLA, RAO V.; MACKMAN, RICHARD L.; SIEGEL, DUSTIN S.; ZENG, XIANHUANG
To: GILEAD SCIENCES, INC.
Reel/Frame 068993/0764 →
Continuity (8)
Continuation 18237152 · Aug 23, 2023
Division 18117858 · Mar 6, 2023
Continuation 18115955 · Mar 1, 2023
Provisional Application 63434993 · Dec 23, 2022
Provisional Application 63424083 · Nov 9, 2022
Provisional Application 63390421 · Jul 19, 2022
Provisional Application 63315769 · Mar 2, 2022
Related Publication 20240246986A1 · Jul 25, 2024
Cited By (4)
US 12,297,226 US 12,448,383 US 12,655,172 US 12,723,057